Status:
TERMINATED
Response of Preterm Infants to Multisensory Stimuli
Lead Sponsor:
University Hospital, Geneva
Conditions:
Mother-Infant Interaction
Eligibility:
All Genders
32-35 years
Phase:
NA
Brief Summary
The aim of this study is to measure the variation of oxytocin and cortisol levels in the saliva of premature neonates and their mother after sensorial stimuli.
Detailed Description
The aim of this study is to measure the variation of oxytocin and cortisol levels in the saliva of neonates with gestational age ranging from 32 to 34 completed weeks and in the saliva of their mother...
Eligibility Criteria
Inclusion
- Newborn gestational age 32 0/7 weeks to 34 6/7 weeks
- Born at university hospital Geneva
- French speaking parents
- Out of incubator
- Signed consent
Exclusion
- Newborn with one of the above conditions:
- Congenital malformation
- intraventricular hemorrhage grade III or IV
- white matter abnormality
- anti-epileptic or sedative drugs
- altered consciousness level
- Infant requiring respiratory support
- psychiatric disorders in the mother or antenatal use of psychoactive drugs
- Bilateral absent otoacoustic emissions and/or auditory evoked potential
- Parents refusal to participate
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04665440
Start Date
September 1 2020
End Date
November 3 2022
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires Genève
Geneva, Switzerland